Minority Diabetes Reports
Thursday, July 17th, 2014
American Journal of Public Health: May 5, 2013 Objectives. We assessed whether community health workers (CHWs) could improve glycemic control among Mexican Americans with diabetes. Methods. We recruited 144 Mexican Americans with type 2 diabetes between January 2006 and September 2008 into the single-blinded, randomized controlled Mexican American Trial of Community Health Workers (MATCH) and followed them for […]
Minority Diabetes Reports
Thursday, July 17th, 2014
ADA: 7/8/14 At nearly 16 percent, American Indians and Alaska Natives have the highest age-adjusted prevalence of diabetes among all U.S. racial and ethnic groups. Read More
Clinical Trial News
Thursday, July 17th, 2014
Diabetes Care July 10, 2014 OBJECTIVE The determinants of insulin-associated weight gain in type 2 diabetes mellitus (T2DM) are partly unknown. Therefore, we conducted a prospective study to identify predictors of insulin-associated weight gain. RESEARCH DESIGN AND METHODS In patients with T2DM, we assessed physical activity by accelerometry and diabetes-related distress measured by questionnaires before and 6 and […]
Clinical Trial News
Thursday, July 17th, 2014
Diabetes Care July 10, 2014 OBJECTIVE The presence of large subcutaneous adipocytes in obesity has been proposed to be linked with insulin resistance and type 2 diabetes through the “adipose tissue expandability” hypothesis, which holds that large adipocytes have a limited capacity for expansion, forcing lipids to be stored in nonadipose ectopic depots (skeletal muscle, liver), where […]
Clinical Trial News
Thursday, July 17th, 2014
The Lancet: 3 July 2014 Background Many patients with advanced type 2 diabetes do not meet their glycated haemoglobin targets and randomised controlled studies comparing the efficacy of pump treatment and multiple daily injections for lowering glucose in insulin-treated patients have yielded inconclusive results. We aimed to resolve this uncertainty with a randomised controlled trial […]
Clinical Trial News, News
Thursday, July 17th, 2014
The Lancet: 16 June 2014 Background Metformin is the recommended first-line pharmacotherapy for patients with type 2 diabetes. There is no consensus on the optimum second-line pharmacotherapy. We compared the efficacy and safety of the sodium glucose cotransporter 2 inhibitor empagliflozin and the sulfonylurea glimepiride as add-on to metformin in patients with type 2 diabetes. Methods […]
Clinical Trial News
Thursday, July 17th, 2014
The Lancet: 02 June 2014 Background Diabetes and non-diabetic dysglycaemia are risk factors for accelerated cognitive decline. In this planned substudy of the Outcome Reduction with Initial Glargine Intervention (ORIGIN) trial, we assessed whether normalising glucose with insulin glargine or administering omega-3 fatty acids in this population may slow this process or affect the development […]
News
Thursday, July 17th, 2014
Diabetes Care: July 14, 2014 OBJECTIVE This study examined specific measures of weight loss in relation to incident diabetes and improvement in cardiometabolic risk factors. RESEARCH DESIGN AND METHODS This prospective, observational study analyzed nine weight measures, characterizing baseline weight, short- versus long-term weight loss, short- versus long-term weight regain, and weight cycling, within the Diabetes Prevention Program […]
News
Thursday, July 17th, 2014
CDC: 7/11/14 New Beginnings: A Discussion Guide for Living Well with Diabetes is an on-line resource that uses stories about African Americans with diabetes to help group leaders lead discussions about the emotional side of living with diabetes, and help people with diabetes identify family and social support needs and develop goal setting, positive coping and problem […]
News
Thursday, July 17th, 2014
JAMA: July 2014 Importance The increasing intensity of diabetes mellitus management over the past decade may have resulted in lower rates of hyperglycemic emergencies but higher rates of hospital admissions for hypoglycemia among older adults. Trends in these hospitalizations and subsequent outcomes are not known. Objective To characterize changes in hyperglycemia and hypoglycemia hospitalization rates and subsequent mortality […]
